Oscar Health, Inc. (OSCR) Institutional Ownership & Insider Trading

401 institutions reported holding Oscar Health, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 62 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OSCROscar Health, Inc.Follow OSCR — free

Healthcare Plans · Healthcare

—

Price chart with a free account

Market cap: 9.6B
P/E TTM: 18.5
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

401 institutions held 64.6% of the shares. Across filers that reported both quarters, shares held changed +14.2%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	401	199	+14.2%	137	109	92	39
Mar 26	327	174	+0.9%	108	48	94	60
Dec 25	331	172	+12.7%	119	40	103	52
Sep 25	327	152	-9.8%	121	74	78	67
Jun 25	322	168	-10.1%	115	73	87	44
Mar 25	285	186	-4.3%	92	58	76	33
Dec 24	256	195	+6.4%	93	41	65	73
Sep 24	279	178	+1.5%	99	54	79	31

Oscar Health, Inc. — questions

Who owns Oscar Health, Inc. stock?: 401 institutions reported Oscar Health, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (6.7%), T. Rowe Price Investment Management, Inc. (4.2%), D. E. Shaw & Co., Inc. (4.1%).
Are Oscar Health, Inc. insiders buying or selling?: 62 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Oscar Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.